Core Insights - BioLargo, Inc. announced the presentation of clinical experience with ViaCLYR™, an advanced wound irrigation solution, showcasing rapid wound transformation, enhanced healing, and strong antimicrobial performance across multiple wound types [1] Company Overview - BioLargo, Inc. is identified as a cleantech and life sciences innovator [1] Clinical Presentation - The clinical results were presented by Dr. Marcus Gitterle at the Boswick Symposium, highlighting a multi-site evaluation involving approximately 36 cases across four wound clinics over a four-month period [1]

Core Insights - BioLargo, Inc. announced that its subsidiary, Clyra Medical Technologies, has received its first commercial stocking order for ViaCLYR™, marking the transition to revenue-generating operations [1][2] Group 1: Product Launch and Commercialization - The stocking order initiates product availability through Advanced Solution's national distribution platform, targeting hospitals, clinics, and healthcare providers across the U.S. [2] - ViaCLYR™ is a highly effective, FDA-cleared wound irrigation solution with over 99.9999% antimicrobial activity, indicated for both acute and chronic wounds [3] - Clyra's commercial readiness includes FDA 510(k) clearance, ISO 13485-certified quality systems, and validated manufacturing processes [4] Group 2: Strategic Vision and Market Position - Clyra's CEO emphasized that the initial commercial order reflects years of development and regulatory execution, laying the groundwork for scalable revenue growth [4] - The milestone is seen as a step forward in BioLargo's strategy to develop differentiated technologies and advance them into commercial markets through partnerships [4] - Clyra plans to expand its product portfolio and advance additional commercialization initiatives as distribution begins [4] Group 3: Company Background - Clyra Medical Technologies focuses on infection control and advanced wound care, leveraging proprietary Copper-Iodine Complex Technology for superior wound care outcomes [5] - Advanced Solution LLC specializes in advanced wound care biologics and medical devices, partnering with healthcare providers to improve patient care [6] - BioLargo, Inc. is a cleantech and life sciences innovator, addressing various environmental and health-related challenges through novel technologies [7][8]